Literature DB >> 22451929

Decade-long bacterial community dynamics in cystic fibrosis airways.

Jiangchao Zhao1, Patrick D Schloss, Linda M Kalikin, Lisa A Carmody, Bridget K Foster, Joseph F Petrosino, James D Cavalcoli, Donald R VanDevanter, Susan Murray, Jun Z Li, Vincent B Young, John J LiPuma.   

Abstract

The structure and dynamics of bacterial communities in the airways of persons with cystic fibrosis (CF) remain largely unknown. We characterized the bacterial communities in 126 sputum samples representing serial collections spanning 8-9 y from six age-matched male CF patients. Sputum DNA was analyzed by bar-coded pyrosequencing of the V3-V5 hypervariable region of the 16S rRNA gene, defining 662 operational taxonomic units (OTUs) from >633,000 sequences. Bacterial community diversity decreased significantly over time in patients with typically progressive lung disease but remained relatively stable in patients with a mild lung disease phenotype. Antibiotic use, rather than patient age or lung function, was the primary driver of decreasing diversity. Interpatient variability in community structure exceeded intrapatient variability in serial samples. Antibiotic treatment was associated with pronounced shifts in community structure, but communities showed both short- and long-term resilience after antibiotic perturbation. There was a positive correlation between OTU occurrence and relative abundance, with a small number of persistent OTUs accounting for the greatest abundance. Significant changes in community structure, diversity, or total bacterial density at the time of pulmonary exacerbation were not observed. Despite decreasing community diversity in patients with progressive disease, total bacterial density remained relatively stable over time. These findings show the critical relationship between airway bacterial community structure, disease stage, and clinical state at the time of sample collection. These features are the key parameters with which to assess the complex ecology of the CF airway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451929      PMCID: PMC3326496          DOI: 10.1073/pnas.1120577109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set.

Authors:  Mangala A Nadkarni; F Elizabeth Martin; Nicholas A Jacques; Neil Hunter
Journal:  Microbiology       Date:  2002-01       Impact factor: 2.777

2.  Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.

Authors:  J Kirk Harris; Mary Ann De Groote; Scott D Sagel; Edith T Zemanick; Robert Kapsner; Churee Penvari; Heidi Kaess; Robin R Deterding; Frank J Accurso; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

3.  Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.

Authors:  Patrick D Schloss; Sarah L Westcott; Thomas Ryabin; Justine R Hall; Martin Hartmann; Emily B Hollister; Ryan A Lesniewski; Brian B Oakley; Donovan H Parks; Courtney J Robinson; Jason W Sahl; Blaz Stres; Gerhard G Thallinger; David J Van Horn; Carolyn F Weber
Journal:  Appl Environ Microbiol       Date:  2009-10-02       Impact factor: 4.792

Review 4.  Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity.

Authors:  Geraint B Rogers; Franziska A Stressmann; Alan W Walker; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2010-03       Impact factor: 5.225

5.  Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data.

Authors:  Mark D Schluchter; Michael W Konstan; Mitchell L Drumm; James R Yankaskas; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

6.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

7.  Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.

Authors:  Geraint B Rogers; Franziska A Stressmann; Garrit Koller; Thomas Daniels; Mary P Carroll; Kenneth D Bruce
Journal:  Diagn Microbiol Infect Dis       Date:  2008-08-09       Impact factor: 2.803

8.  Characterizing aggressiveness and predicting future progression of CF lung disease.

Authors:  Michael W Konstan; Jeffrey S Wagener; Donald R VanDevanter
Journal:  J Cyst Fibros       Date:  2009-06       Impact factor: 5.482

9.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

10.  Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum.

Authors:  Jiangchao Zhao; Lisa A Carmody; Linda M Kalikin; Jun Li; Joseph F Petrosino; Patrick D Schloss; Vincent B Young; John J LiPuma
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

View more
  268 in total

1.  Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.

Authors:  Joshua R Stokell; Raad Z Gharaibeh; Timothy J Hamp; Malcolm J Zapata; Anthony A Fodor; Todd R Steck
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

Review 2.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 3.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

4.  Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis.

Authors:  Jiangchao Zhao; Charles R Evans; Lisa A Carmody; John J LiPuma
Journal:  J Cyst Fibros       Date:  2015-02-26       Impact factor: 5.482

5.  Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.

Authors:  Mark Bazett; Lisa Honeyman; Anguel N Stefanov; Christopher E Pope; Lucas R Hoffman; Christina K Haston
Journal:  Mamm Genome       Date:  2015-02-27       Impact factor: 2.957

6.  Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.

Authors:  William G Flight; Ann Smith; Christopher Paisey; Julian R Marchesi; Matthew J Bull; Phillip J Norville; Ken J Mutton; A Kevin Webb; Rowland J Bright-Thomas; Andrew M Jones; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 7.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 8.  Pseudomonas aeruginosa polymicrobial interactions during lung infection.

Authors:  Karishma Bisht; Jiwasmika Baishya; Catherine A Wakeman
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

9.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

10.  Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.

Authors:  Laura M Filkins; Jyoti A Graber; Daniel G Olson; Emily L Dolben; Lee R Lynd; Sabin Bhuju; George A O'Toole
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.